I-VAC
Toolkit

Last Updated March 15, 2024

COVID-19 VACCINE ADMINISTRATION
SELF-GUIDED EDUCATION MODULES

This toolkit is specifically designed to aid clinicians and healthcare organizations in developing effective tactics for the incorporation of COVID-19 vaccination into routine clinical workflows. This toolkit is not meant to replace required federal or state trainings, but to act as supplemental information to help drive more efficient vaccine implementation throughout Illinois.

The information provided within these toolkits and on this landing page was last updated on March 15, 2024.

This Toolkit Includes Information and Resources On:

  • COVID-19 vaccine administration and distribution (I-CARE, working with local health departments, etc.)
  • Operational issues
  • Handling and preparation of COVID-19 vaccines
  • Post-vaccine process
  • Implementing COVID-19 vaccine mandates in your workplace
  • Strategies for overcoming vaccine hesitancy through culturally and linguistically appropriate methods
  • How to use data to support vaccine uptake

HOW TO USE THIS TOOLKIT

Download the complete toolkit or individual sections based on your needs. Each toolkit section includes an interactive PDF with live links to key resources and source material.

All resources and source material links for each toolkit section can be found under the “Resources” portion of this page, organized by section and page number.

Woman Being Vaccinated

RESOURCE LINKS

If you are using the printed version of the self-guided COVID-19 vaccination toolkit, please use the resource guide below to view all corresponding resources and source material by section. Here you will find all the links to each resource referenced within the toolkit.

5-4

FDA approved treatments

5-5

CDC‭: ‬COVID-19‭ ‬vaccination and MIS-C and MIS-A

5-6

Recommended Action(s): same type of COVID-19 vaccine

Recommended Action(s): COVID-19‭ ‬vaccination and MIS-C and MIS-A

Recommended Action(s): COVID-19 vaccination and myocarditis and pericarditis

Appendix E

FDA EUA fact sheets

5-7

Clinical Immunization Safety Assessment COVIDvax

Appendix D

Frequently Asked Questions

Managing Anaphylaxis

5-8

CDC: Use of COVID-19 Vaccines in the United States

CDC: Contraindications and Precautions

Illinois.gov: Vaccination Eligibility

5-9

CDC’s latest recommendations

5-18

‭‬Vaccine Adverse Event Reporting System‭ (‬VAERS‭)‬

Interchangeability of COVID-19‭ ‬vaccines

CDC: Use of COVID-19 Vaccines in the United States

CDC: COVID-19 Vaccine Boosters

CDC: Updates to the Evidence to Recommendation Framework: Pfizer-BioNTech and Moderna COVID-19 vaccine booster doses

5-19

Table 1

Table 2

Timing‭, ‬spacing‭, ‬and interchangeability of COVID-19‭ ‬vaccines

COVID-19 Vaccine: Vaccine Administration Competencies Assessment Form-February 28, 2021

5-20

For supplementary material on Intramuscular Injection Children 7 through 18 years of age please follow this PDF.

CDC: Vaccine Administration: Needle Gauge and Length

5-21

CDC: Use of COVID-19 Vaccines in the United States

Timing‭, ‬spacing‭, ‬and interchangeability of COVID-19‭ ‬vaccines

5-22

CDC: How to Increase COVID-19 Vaccination upon Discharge from Hospitals, Emergency Departments & Urgent Care Facilities

5-23

From the CDC: There is no VIS for COVID-19 vaccines authorized under an EUA. Instead, the FDA-issued EUA Fact Sheet for Recipients and Caregivers for each COVID-19 vaccine must be used.

CDC: Healthcare Providers/ Professionals

5-24

CDC: Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

5-25

IDPH Account Portal

IDPH: Vax Verify

5-30

U.S. COVID-19 Vaccine Product Information

Moderna

6 months through 4 years Updated 2023-2024 Moderna COVID-19 Standing Orders

5 years and older Updated 2023-2024 Moderna COVID-19 Standing Orders

Pfizer

6 months through 4 years Updated 2023-2024 Pfizer-BioNTech COVID-19 Vaccine Standing Orders

5 years and older Updated 2023-2024 Pfizer-BioNTech Standing Orders

Novavax

Novavax COVID-19 Vaccine (Monovalent) Standing Orders for Administering Vaccine 12 years and Older

6-3

Pfizer Local & Systematic Reactions

Moderna Local & Systematic Reactions

Novavax Local & Systematic Reactions

6-4

NIH: Q&A: COVID-19, Vaccines, and Myocarditis

6-5

CDC: Table 1

CDC: Update on myocarditis following mRNA COVID-19 vaccination

CDC: Recommendations for Pfizer-BioNTech and Moderna COVID-19 Vaccine Primary Series in Children 6 Months through 5 Years Old

6-7

CDC: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination

6-8

CDC Center for Preparedness and Response

CDC: Pfizer/BioNTech BNT162b2 (COVID-19 Vaccine, mRNA) Vaccine –in Individuals 5 to <12 Years of Age

6-9

VAERS: Writable PDF Form

VAERS: Upload Completed Writable PDF Form

CDC: Reporting Adverse Events Following Vaccination

6-10

CDC: Preventing Vaccine Administration Errors

6-11

CDC: Considerations for Timing of COVID-19 Vaccination in Relation to Immunosuppressive Therapies

6-12

Table 1

Table 2

CDC: Interim Clinical Considerations, Appendix B

6-13

CDC: Table 1

CDC: Table 2

6-14

General Best Practices Guidelines

6-15

8 Weeks

Rare Risk of Myocarditis and Pericarditis

FDA Authorization

Transitioning from a younger to older age group

Considerations for extended intervals for COVID-19 vaccine doses

Package Inserts

EUA fact sheets for healthcare providers

CDC: COVID-19 Vaccine Administration Errors and Deviations

6-16

CDC: Science Brief

CDC: Morbidity and Mortality Weekly Report, January 14, 2022

6-18

CDC: Guidance on Vaccinations Given Outside of the U.S.

Table 1

Table 1

CDC: Interim Clinical Considerations for Use of COVID-19 Vaccines

6-19

Table 1

Table 2

CDC: Interim Clinical Considerations for Use of COVID-19 Vaccines

6-20

CDC: Emergency Use Instructions (EUI) Fact Sheet for Recipients and Caregivers: Pfizer-BioNTech COVID-19 Vaccine for Primary, Additional, and/or Booster Doses

6-21

CDC: COVID-19 Vaccines While Pregnant or Breastfeeding

6-22

January 2022 Study

2023 MMWR Study

2021 MMWR Study

CDC: COVID-19 Vaccines While Pregnant or Breastfeeding

ACOG Guidelines

6-24

Illinois.gov Guidance Affirming Non-Discrimination in Medical Treatment

CDC: People with Disabilities

AAP: COVID-19 Vaccination for Children and Youth with Developmental Disabilities

CDC’s Website

AAP’s Website

7-4

AAP: Reminder and Recall Strategies

7-5

COVID-19 Vaccine Prioritization Project

7-6

COVID-19 Vaccine Prioritization Project

7-7

COVID-19 Data Tracker

7-8

IDPH data dashboard

COVID-19 Vaccine Monitor: Parents and the Pandemic

COVID-19 Vaccine Search Insights

Technical docs

7-9

View Additional Outreach Materials

7-11

CDC COVID-19 Vaccination Field Guide: 12 Strategies for Your Community

7-12

KFF: COVID-19 Cases and Deaths by Race/Ethnicity: Current Data and Changes Over Time

7-14

Guidance on Inclusive, Anti-biased Language

7-15

The New England Journal of Medicine: How Structural Racism Works

The Commonwealth Fund: Understanding and Ameliorating Medical Mistrust Among Black Americans

CDC: CDC COVID-19 Response Health Equity Strategy: Accelerating Progress Towards Reducing COVID-19 Disparities and Achieving Health Equity

The Commonwealth Fund: Confronting Racism in Healthcare

Kaiser Family Foundation: COVID-19 Vaccine Monitor Dashboard – Equity

7-22

Immigrant Communities: These videos

Immigrant Communities: Social media samples

Rural Communities: Fact Sheet on Expanding COVID-19 Response in Rural Communities through Rural Health Clinics

Rural Communities: National Rural Health Association – List of resources

People with Disabilities: CDC-Toolkit with resources

People Living in Congregate Settings: CDC Guidance on Management of COVID-19 in Homeless Service Sites and in Correctional and Detention Facilities

Pregnant Populations: American College of Obstetricians and Gynecologists-Toolkit with resources